Faculty of Dentistry, University of Toronto, 124 Edward St, Toronto, Ontario, Canada.
Institute of Biomedical Engineering, University of Toronto, 164 College St, Toronto, Ontario, Canada.
J Mater Chem B. 2022 Aug 31;10(34):6453-6463. doi: 10.1039/d1tb02121d.
Infection at the surgical site for dental implants results in failed procedures, patient pain, burdensome economic impact, and the over-prescription of prophylactic antibiotics. Mesoporous silica films as coatings for implants may provide an ideal antimicrobial drug storage and local release vector to the site of infection, however traditional drug loading techniques result in insufficient drug load and short-term release kinetics. In this work, we have applied a method to use a surfactant-antimicrobial drug octenidine dihydrochloride (OCT) as a template for mesostructured silica, to demonstrate silica-OCT composite films. The films are synthesized by evaporation induced self-assembly (EISA) and we explore the effects of synthesis parameters on porous film structure, OCT incorporation, and OCT drug release rates. Drug micelle incorporation into the silica mesostructure was highly dependent on silica precursor pre-reaction to form silica oligomers before film spin-casting. The OCT drug concentration of the synthesis solution dictated the time required for effective incorporation (without phase separation), with total loading in the film of up to 90% by mass. The OCT content in the films was found to directly determine the timescale of drug release, from 2 to 8 h for a single layer film. The total release timescale was increased by the addition of multiple layers of OCT-silica films to nearly 2 weeks. Drug release from films completely inhibited (UA159) growth, while drug-free porous silica films showed no increase in bacterial growth over non-porous control. These OCT-silica films have a significant potential to store and release antimicrobial drugs from dental implant surfaces.
种植体周围的感染会导致手术失败、患者疼痛、经济负担沉重,以及预防性抗生素的过度使用。作为种植体涂层的介孔硅膜可能为感染部位提供了理想的抗菌药物储存和局部释放载体,但传统的药物加载技术导致药物负载不足和短期释放动力学。在这项工作中,我们应用了一种方法,将表面活性剂-抗菌药物盐酸奥替尼啶(OCT)用作介孔硅的模板,以展示硅氧烷-OCT 复合膜。通过蒸发诱导自组装(EISA)合成薄膜,我们探索了合成参数对多孔薄膜结构、OCT 掺入和 OCT 药物释放率的影响。药物胶束掺入硅介孔结构高度依赖于硅前体的预反应,以在旋涂薄膜之前形成硅氧烷低聚物。合成溶液中的 OCT 药物浓度决定了有效掺入(无相分离)所需的时间,薄膜中最高可达 90%的质量总负载。发现薄膜中的 OCT 含量直接决定了药物释放的时间尺度,单层薄膜的释放时间为 2 至 8 小时。通过添加多层 OCT-硅氧烷薄膜,总释放时间尺度延长至近 2 周。药物释放完全抑制了(UA159)的生长,而无药物的多孔硅氧烷薄膜在非多孔对照下没有增加细菌生长。这些 OCT-硅氧烷薄膜具有从牙科植入物表面储存和释放抗菌药物的巨大潜力。